Home
Login Register
> Return

Go to Forum     Add To MyCorner

Biolidics8YY

0.022 No Change

Group

Cash   

Cash

Singapore Dollar   

26-Jun 17:04

 

TRADING INFO

Open

-   

Buy

0.022   

High

-   

Low

-   

Previous Close

0.022   

Volume(K)

0.0   

Buy Volume(K)

898.0   

Sell Volume(K)

898.0   

 

KEY STOCK INFO

PE Ratio

NA   

Dividend Yield

-   

Price to Book Ratio

-   

Market Cap

-   

Enterprise Value

-   

52 Weeks High

0.033   

52 Weeks Low

0.008   

RSI

49.81 ( No Info )   

Williams %R

49.81 ( No Info )   

 

COMPANY INFORMATION Financial Info by

SIC

MEDICAL LABORATORIES   

Address

37 JALAN PEMIMPIN #02-07 MAPEX SINGAPORE 577177   

Phone

(65)   

Fax

(65) 6482 0668   

SIC

We are a Singapore-based medical technology company focusing on the development of cellenrichment systems which, when combined with other analytical tests, have a wide range of</BR>applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.   

AUDITOR

BAKER TILLY TFW LLP   

 

FINANICALS INFORMATION All values in $millions

  
    

Financial Year

2023-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

-180.608   

Return on Equity Capital(%)

135.328   

Net Profit Margin(%)

-189.202   

Current Ratio

0.224   

Debt to Capital at Book

2.966   
INCOME STATEMENT

EBITDA

-2112.0   

EBITDA

-2367.0   

Net Profit

-2488.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

0.0   

Fixed Assets

0.006   

Long Term Investments

0.0   

Stock/Inventories

11.0   

Cash

183.0   

Current Liabilities

1920.0   

Long Term Debt

613.0   

Provisions

10.0   

Minorities

0.0   

Total Shareholder Equity

-1.989   
PER SHARE INFO

EBITDA per share

-0.003   

EBIT per share

-0.004   

Profit per share

-0.004   

Book Value per share

-0.003   

Financial Year

2022-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

-388.992   

Return on Equity Capital(%)

-2911.18   

Net Profit Margin(%)

-376.617   

Current Ratio

0.985   

Debt to Capital at Book

0.495   
INCOME STATEMENT

EBITDA

-4541.0   

EBITDA

-9766.0   

Net Profit

-9374.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

0.0   

Fixed Assets

0.061   

Long Term Investments

0.0   

Stock/Inventories

27.0   

Cash

5029.0   

Current Liabilities

6008.0   

Long Term Debt

1693.0   

Provisions

15.0   

Minorities

0.0   

Total Shareholder Equity

-1.688   
PER SHARE INFO

EBITDA per share

-0.009   

EBIT per share

-0.02   

Profit per share

-0.019   

Book Value per share

-0.003   

Financial Year

2022-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

-388.992   

Return on Equity Capital(%)

-2911.18   

Net Profit Margin(%)

-376.617   

Current Ratio

0.985   

Debt to Capital at Book

0.495   
INCOME STATEMENT

EBITDA

-8584.0   

EBITDA

-9767.0   

Net Profit

-9374.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

0.0   

Fixed Assets

0.061   

Long Term Investments

0.0   

Stock/Inventories

27.0   

Cash

5029.0   

Current Liabilities

6008.0   

Long Term Debt

1693.0   

Provisions

15.0   

Minorities

0.0   

Total Shareholder Equity

-1.688   
PER SHARE INFO

EBITDA per share

-0.017   

EBIT per share

-0.02   

Profit per share

-0.019   

Book Value per share

-0.003   
Important: Please read our Terms and Conditions and Privacy Policy .